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Over the last decade excellent progress has been made globally in HIV 
management thanks to antiretroviral therapy (ART) rollout and 
international guidelines now recommending immediate initiation of 
ART in people living with HIV. Despite this, advanced HIV disease (CD4 
less than 200 cells/mL) and opportunistic infections remain a 
persistent challenge and contribute significantly to HIV-associated 
mortality, which equates to 23,000 deaths in Uganda in 2018 alone. 
Our Meningitis Research Team based in Uganda is committed to 
conducting clinical trials to answer important questions regarding 
diagnostics and management of HIV-associated opportunistic 
infections, including tuberculosis and cryptococcal meningitis. 
However, clinical research is impossible without research participants 
and results are meaningless unless they are translated into benefits 
for those affected by the disease. Therefore, we held a series of 
community engagement events with the aims of 1) giving research 
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participants a voice to share their experiences of clinical research and 
messages of hope around advanced HIV disease with the community, 
2) dispelling myths and stigma around HIV, and 3) raising awareness 
about the complications of advanced HIV disease and local clinical 
research and recent scientific advances. The purpose of this Open 
Letter is to describe our community engagement experience in 
Uganda, where we aimed to give clinical research participants a 
greater voice to share their experiences. These activities build upon 
decades of work in HIV community engagement and lays a platform 
for future research and engagement activities.
Keywords 
Public engagement, advanced HIV diseases, meningitis, clinical 
research
Carolina, Chapel Hill, USA
Any reports and responses or comments on the 
article can be found at the end of the article.
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Introduction
Substantial progress has been made in the treatment and 
prevention of HIV in the last decade thanks largely to the 
widespread roll out of antiretroviral treatment (ART) and 
recommendation to treat all people living with HIV (PLHIV) 
regardless of CD4 cell count. The ambitious UNAIDS 
“90-90-90” target states that, by 2020, 90% of PLHIV should 
be diagnosed, 90% of those diagnosed initiated on ART, and 
90% of those on ART should be virally suppressed (HIV viral 
load <50 copies/ml), aiming to reach the Sustainable Devel-
opment Goal of ending the HIV epidemic by 20301. The 
global efforts to achieve these targets are demonstrated by a 
55% decline of AIDS-related deaths between 2004 and 20182.
While unquestionable strides in starting people on ART have 
been made, gains in recent years are decreasing and 23,000 
people died from HIV-related illness in 2018 in Uganda alone2. 
This is in part due to the remaining challenge of advanced HIV 
disease, defined by the World Health Organisation (WHO) as 
having as CD4 cell count less than 200 cell/µL or clinical 
stage III or IV disease3. Uganda is making good progress 
towards the “90-90-90” targets, with 84% aware of their HIV 
status, 87% of those who are HIV positive on treatment and 
88% of those on treatment virally suppressed, however, stigma 
still acts as a barrier to seeking HIV testing and care4. Moreover, 
those who successfully test may not link to care early enough 
due to systemic barriers. Data suggest that in sub-Saharan 
Africa at least one-third of people starting on ART present 
with advanced HIV disease, a fact which requires addressing 
if global targets are to be reached5.
Our Meningitis Clinical Research Team based at the Infectious 
Diseases Institute (IDI) Kampala and Mbarara Regional Refer-
ral Hospital Uganda, is dedicated to reducing advanced HIV-
associated mortality by improving the diagnosis and treatment 
of common opportunistic infections, including cryptococcal 
and tuberculosis meningitis. Together cryptococcal disease and 
tuberculosis cause over half of HIV-related deaths6,7.
Public engagement seeks to overcome the disconnect between 
scientists and the community, making research more meaningful 
for the public and scientists alike. It can serve to improve 
uptake of research studies and can tackle suspicion about the 
intention of scientists. Three broad and often overlapping 
purposes (or pillars) of public engagement are: 1) to ‘transmit’ 
in order to inspire and inform, change, educate, build capac-
ity and involvement, influence decisions; 2) to ‘collaborate’ in 
order to consider, create or decide something together; 3) to 
‘receive’ in order to use the views, skills, experience of the public 
to inspire and inform our own capacity (Figure 1)8. The specific 
roles of the Meningitis Clinical Research Team in ‘transmitting’, 
‘receiving’ and ‘collaborating’ varied according to the type of 
outreach activity.
Globally, there is a strong history of community stakeholder 
engagement and activism among PLHIV. This is particu-
larly true in Uganda, where community engagement has long 
been a priority of civil society groups, such as The AIDS Sup-
port Organisation (TASO) based on the Greater Involvement of 
People Living with HIV/AIDS (GIPA) principles9. We aimed 
to build on these efforts and also believe it is critical to ensure 
research participants have a voice to share their experiences and 
an opportunity to become advocates of clinical research and 
the condition being studied; their messages may improve the 
wellbeing and save the lives of others in their communities. 
With the support of public engagement funding through 
London School of Hygiene and Tropical Medicine and 
Makerere University/Uganda Virus Research Institute Infec-
tion and Immunity Centre of Excellence, we designed and 
Figure 1. Purposes and pillars of public engagement.
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implemented a series of multifaceted events between December 
2018 and January 2020. The overarching aims included giv-
ing clinical research participants (who are survivors of advanced 
HIV disease) a voice in sharing their experiences of clinical 
research and messages of hope around advanced HIV disease 
with the community. This included dispelling myths and 
stigma around HIV, raising awareness about local ongoing 
clinical research in the field and recent scientific advances. 
We addressed our aims by engaging a variety of audiences 
including healthcare workers through knowledge exchange ses-
sions, and thereafter the community and stakeholders in the HIV 
field through community advisory board meetings, radio, tel-
evision and two community events. In this letter, using the three 
pillars of public engagement (transmit, collaborate and receive), 
we discuss the planning, conduct and outcomes of our public 
engagement events.
Knowledge exchange with district healthcare workers. 
Audience: Health care workers. Purpose: Transmit, 
receive and collaborate
For PLHIV presenting with symptoms of meningitis or low 
CD4+ T cell count, the WHO recommends point-of-care 
cryptococcal antigen testing (a rapid test for a fungal infec-
tion, which causes meningitis in immunocompromised people). 
However, we noted that most patients were referred on to 
Kiruddu and Mbarara referral hospitals at a late stage of 
illness, without prior lumbar puncture (a clinical procedure 
performed to collect cerebrospinal fluid via a needle placed 
in the base of the back which is essential for diagnosing 
meningitis, also known as ‘spinal tap’) or cryptococcal antigen 
testing3. We visited 21 peripheral health centres in Kampala 
and 4 centres in Mbarara within the catchment area for Kiruddu 
and Mbarara hospitals respectively. These were mainly level 
IV healthcare facilities (HCIV) or district hospitals offering 
HIV prevention, care and treatment services to HIV-positive 
clients. In these interactive ‘knowledge exchange’ sessions the 
meningitis team had three aims. We transmitted information to 
the healthcare workers using posters, infographic leaflets and 
power point presentations detailing the aetiology, pathogenesis, 
clinical presentation, diagnostic challenges, available treat-
ment options and opportunities that clinical trials present in 
improving treatment and care of PLHIV. We also ‘received’ and 
‘collaborated’ with healthcare workers by discussing their 
experiences and challenges managing advanced HIV disease 
and potential solutions (e.g. helping with patient referrals 
and diagnostics such as providing CrAg tests) (Figure 2 and 
Figure 3). 
An average of 40 people attended each session and the audi-
ence comprised of healthcare workers including physicians, 
medical officers, clinical officers, nurses, laboratory person-
nel, and medical students. The evaluation of these sessions was 
performed by informal verbal feedback and discussions with 
staff who attended the teaching sessions. Staff appreciated 
having up-to-date teaching to ensure they would recognize 
advanced HIV disease, cryptococcal and tuberculosis men-
ingitis, and felt empowered to refer to the hospital. They also 
appreciated understanding what resources were available to 
ensure they could get the best care for their patients. A working 
relationship was established between the meningitis research 
team and health workers in the clinics we visited.
Community and stakeholder engagement
We recognise that challenges in healthcare seeking behaviour 
in advanced HIV are multifactorial, influenced by policy, 
healthcare systems, and community cultural, socioeconomic 
and geographical factors, to name but a few10. We therefore 
undertook a multifaceted approach to maximise community 
engagement and information dissemination around the Kampala 
region as follows.
Community Advisory Board Meetings. Audience: 
Community representative. Purpose: Receive and 
collaborate
The IDI Community Advisory Board (CAB; comprised of 
patient representatives, spiritual leaders, stakeholders and pri-
vate sector) met with our study team on two occasions to dis-
cuss the aims and potential content of our proposed community 
outreach activities (Figure 4). Our aim within these meet-
ings was to ‘receive’ opinions and suggestions from the CAB 
on our proposed outreach activities, and agree appropriate 
channels of information dissemination and adapting the content 
and language used to ensure cultural sensitivity Together, we 
agreed a schedule of events, including a circus event, a televi-
sion and radio shows, and a ‘Journey of Hope’ event. The mem-
bers of the CAB also activiely ‘collaborated’ in activities by 
attending events and a member of the CAB featured in the 
TV event.
Circus event in community center. Audience: Adults in 
the community who may be disengaged from HIV care. 
Purpose: Transmit
In this event the aim of meningitis research team was to 
transmit: engaging with hard-to-reach young adults who may be 
disengaged from HIV care or untested in order to raise aware-
ness about meningitis, the safety of lumbar punctures and ongo-
ing meningitis clinical research. Using a local social circus 
group, we attracted a large audience of around 250 people using 
Figure 2. Knowledge exchange session in Western Uganda.
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interactive community performances, music, acrobatics, jug-
gling, fire breathing and a drama sketch of a patient journey 
through meningitis illness (Figure 5). A trial participant (Mr JS), 
Dr Meya (Principal Investigator), Dr Stephen Watiti (an HIV 
advocate) and a Research Medical Officer did a structured 
question and answer (Q&A) session with the audience. We 
conducted formal exit interviews with the audience to ensure 
that the correct messages had been retained and to receive feed-
back from attendees. Quotes from exit interviews included “the 
event corrected wrong thoughts about meningitis, that it’s a 
Figure 3. Infographic leaflets distributed to share information about TB meningitis and the RifT clinical trial. The RifT clinical trial 
studied the safety, tolerability and pharmacokinetics of high dose rifampicin compared to standard of care TBtreatment of adult tuberculous 
meningitis in Uganda. 
Figure 4. Infectious Diseases Institute Community Advisory 
Board Meeting. Figure 5. Public audience drawn to the circus event.
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citizens and long-standing myths regarding HIV/AIDS. Few 
people with HIV can openly talk about their status and this 
stigma has led to challenges in reaching the UNAIDS 90-90-90 
targets, with 70,000 new HIV infections annually in Uganda and 
1 in 3 people presenting with advanced HIV disease13. The key 
message of this 1-hour television (TV) show, with a wide 
national audience was that ‘advanced HIV disease is prevent-
able and treatable’. The show was aired on National TV on 
the World AIDS day 2019 and featured Drs John Kasibante 
(Research Medical Officer) and Fiona Cresswell (Principal 
Investigator) and Mr Tugume, a former research participant 
(Figure 7). Mr Tugume openly educated people on life as a 
survivor of advanced HIV disease. He helped demystify key 
issues such as Undetectable = Untransmissible: early initiation 
of antiretrovirals to achieve viral suppression and to prevent HIV 
transmission to loved ones.
During the panel discussion questions arose like “can someone 
with HIV live with one who doesn’t have HIV and she doesn’t 
get the infection?”, to which Mr Tugume responded “yes, my 
wife is HIV-negative, we are raising our son who is also 
HIV-negative and are soon to have another child”. Mr Tugume 
also helped to reduce anxiety around lumbar punctures when 
asked “do people die from lumbar punctures?” and replied “No, 
I got many lumbar punctures when I was being treated for 
cryptococcal meningitis in Mulago, and here I am talking with 
you. They didn’t kill me but saved my life”. This is an example 
of collaborating with a former research participant to trans-
mit key information to the public. We also received queries and 
viewpoints from the public.
‘A Journey of Hope’ – Research participant and stakeholder 
event. Audience: Research participants, institutional 
leaders, stakeholders. Purpose: Transmit and 
collaborate
‘A Journey of Hope’ was a celebratory event bringing together 
clinical trial participants, the IDI Meningitis Research Team, 
key stakeholders including Centre for Disease Control, U.S. 
Mission Uganda, Chair of the Mulago Hospital Institutional 
Review Board, an internationally renowned HIV patient 
advocate Dr Stephen Watiti, Executive Director of IDI and 
the research office. The IDI Drama Group performed cultural 
Figure 7. Dr Kasibante, Dr Cresswell and Mr Tugume appear 
on NTV.
cultural disease or witchcraft”, “the event was very good and 
it helped people or the community to learn many things in 
this area”, “Lumbar punctures are not the cause of death in 
sick people”, “headache, tiredness, neck pain are symptoms 
of meningitis”.
Radio shows on Central Broadcasting Services. Audience: 
Community members in central districts of Uganda. 
Purpose: Receive, transmit and collaborate
Radio, described as “Africa’s medium of choice in the global 
age”, remains an important medium of communication in 
Uganda, in part due to its accessibility11. We harnessed the 
popularity of radio in attempting to access hard-to-reach 
populations and aired a series of events on Central Broadcast-
ing Services (CBS) radio, the largest radio station in Uganda. 
CBS is home to the most popular Breakfast show in Uganda, 
and a has a large following across different age groups12. The 
aim of this radio show was to allow the Research Medical 
Officers to ‘transmit’ important scientific content to the 
listeners, and also to ‘collaborate’ by co-creating the contents of 
the radio material with former trial participants, who were able 
to share their experiences - a focal point of the show. (Figure 6). 
In the week leading into World AIDS Day 2019 pre-recorded 
material including testimonials from three clinical trial 
participants who have survived advanced HIV disease were 
broadcast sharing key messages around symptoms of menin-
gitis, experiences with lumbar punctures and clinical research, 
their treatment and return to health. On World AIDS day itself, a 
Research Medical Officer on the team featured on the radio 
and fielded questions from the presenters and public around 
advanced HIV disease, consistent with the ‘receive’ pillar of 
the public engagement framework.
National Television Show. Audience: Community who 
may be disengaged from HIV care or carrying myths or 
stigma relating to HIV/AIDS. Purpose: Receive , transmit 
and collaborate
HIV continues to be the most stigmatizing infection in Uganda, 
in part due to the lack of evidence-based information reaching 
Figure 6. Study physician Dr Ssembambulidde records 
material for CBS radio broadcasts.
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Discussion
Whilst it is challenging to measure the exact impact of these 
activities we know that we engaged with around 500 healthcare 
workers, 250 members of the public face-to-face, several 
thousand members of the public through TV and radio, around 
80 research participants and a number of key stakeholders in 
the HIV field. Four former trial participants have come forward 
as strong advocates for living well with HIV and continue to 
spread messages of hope in their communities. We learned 
the importance of harnessing the voices and opinions of the 
public in planning and conduct of engagement activities and in 
the planning of future research activities aimed at combating 
advanced HIV disease. In addition to optimising medical 
management as stipulated in the WHO advanced HIV care 
package, we believe addressing late presentation requires a 
holistic approach, with engagement and education of healthcare 
workers and the community14,15.
While there has been a huge amount of positive work in 
community engagement in PLHIV in Uganda, sometimes 
public engagement is can be overlooked in academic research. 
There can be a focus on volume of publications in peer-reviewed 
scientific journals leading to a lack of value placed on dis-
semination to the wider public16. However, in an era of digi-
talisation where ‘fake news’ surreptitiously invades our 
media sources, it is more important than ever for researchers 
to take a stand and accurately disseminate research findings to 
populations who are most affected. As public-researcher inter-
action improves, so too will trust in science, which may 
encourage broader public participation in scientific pursuits such 
as clinical research. We also feel it is critical to give research 
participants a voice to share their experiences and become 
advocates of science in the community.
In this letter we have shared our attempt to close the gap 
between HIV clinical research and the wider public using 
research participants as partners in delivering a unique variety 
of novel engagement activities. Our work lays the foundation 
for future engagement activities and research into the benefits 
and best practice around public engagement activities.
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dances and a dramatization around meningitis (Figure 8) to 
address stigma and myths surrounding lumbar punctures and 
meningitis management (‘collaborate’). A number of trial 
participants spoke about their experiences in clinical research. 
The event was also used as a platform to disseminate scien-
tific results to trial participants and important stakeholders 
(‘transmit’). The ‘Journey of Hope’ symbolised a very diffi-
cult journey for patients and their caretakers, many of whom 
had at times lost hope and were now celebrating with their 
families and former doctors, empowered to act as community 
advocates to improve understanding about advanced HIV. 
Attendees feasted and cut cake together to celebrate the progress 
made so far (Figure 9). We hope to repeat this successful 
event in the future on the completion of further clinical 
trials.
Figure 8. Dramatisation of meningitis illness by IDI drama 
group.
Figure 9. Cake cutting with the research team, study 
participants and IDI Executive Director.
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article was to share how the research team utilized public engagement strategies to: give clinical 
research participants platforms to share their experiences as research volunteers; dispel myths 
around HIV and procedures related to advanced HIV disease care and treatment; and raise 
awareness about their ongoing research studies. 
  
The Open Letter provides a brief and useful summary of their main engagement activities, as 
organized around a model of three pillars of public engagement: transmit; receive; and 
collaborate. These pillars provide a useful framework for the Letter, and adding succinct details on 
the roles, benefits and challenges faced by the two main implementing partners (i.e. research 
group and clinical research participants) would further strengthen the Letter. In particular, the 
inclusion of the ‘audience’ for each sub-section was helpful, and I recommend additionally 
specifying who is imparting these experiences, skills, and knowledge for each pillar. For example, 
in Figure 1, for ‘Transmit’ – does the model indicate the research participants are providing the 
inspiration, and doing the educating and influencing public decisions by sharing their life 
experiences as part of an advocacy strategy? Or are only the researchers seen as transmitters and 
the public (which presumably includes study participants) are positioned as receivers?) Were there 
any challenges in having participants or researchers deliver messages? Clarifying the roles of 
researchers, study participants and the public as outlined by the model will help the reader better 
understand the dynamics and added value in delivering these engagement activities in 
partnership. Please also include a complete citation (#6) in the references for this model. 
  
Second, it was wonderful reading about the multi-pronged approach and array of creative 
community-level and media activities undertaken as part of the series. These activities are 
commendable, and I would encourage the authors to further acknowledge the decades of 
community stakeholder efforts in the HIV research field that preceded them. While it may be 
accurate that ‘public engagement is often overlooked in academic research’ broadly, this cannot 
be said for HIV research specifically. From the Greater Involvement of People Living with HIV/AIDS 
(GIPA) principles to trail-blazing civil society groups like TASO in Uganda, people living with HIV 
have always actively demanded their voices be heard and have played crucial roles in contributing 
to the development and implementation of HIV research, policy, and care and treatment services 
both globally and in Uganda. This context provides important and differing perspectives; and 
helps maintain our accountability as researchers to the communities in which we work. 
  
Further, the Letter makes a strong case for Uganda’s ongoing need to conduct research designed 
to improve the diagnosis and treatment of common opportunistic infections that contribute to 
advanced HIV-associated mortality. Minor comments about the research itself that are intended to 
improve clarity and readability overall include:




For Figure 3 – Please clarify if these are actual clinical research recruitment materials that 
have been approved by a local research ethics committee. 
 
○
Recommend adding a line to describe the RIFT Study. 
 
○
Request clarification about whether the event, “A Journey of Hope” was a one-off or 
recurring event? And was it convened around a specific study or a broader research 
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they “celebrated the progress made so far” – which implies there is still ongoing research, 
and thus potentially future events to come? These are important factors to note as they can 
directly and indirectly impact a group's ability to build trust with the public.
Additional citations, especially where statistics are provided, would strengthen this Letter, and 
benefit readers. For example, the following sentences ought to include references:




“….70,000 new HIV infection annually in Uganda, and 1 in 3 people presenting with 
advanced HIV disease” Pg. 6.
○
Thank you again for sharing your community engagement work with the field. I look forward to 
seeing how your research and your relationships with the community continue to evolve and 
strengthen over time as you carry out this important research in reducing advanced HIV disease 
mortality.
 
Is the rationale for the Open Letter provided in sufficient detail?
Yes
Does the article adequately reference differing views and opinions?
Partly
Are all factual statements correct, and are statements and arguments made adequately 
supported by citations?
Partly
Is the Open Letter written in accessible language?
Yes
Where applicable, are recommendations and next steps explained clearly for others to 
follow?
Yes
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Good Participatory Practices (GPP) in HIV research; stakeholder and 
community engagement; participatory and mixed methods research; HIV biomedical prevention 
research
I confirm that I have read this submission and believe that I have an appropriate level of 
expertise to confirm that it is of an acceptable scientific standard, however I have 
significant reservations, as outlined above.
Author Response 18 Oct 2020
fiona cresswell, Infectious Diseases Institute, Kampala, Uganda 
We thank the reviewers for taking the time to review our manuscript, and for their detailed and 
AAS Open Research
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thought-provoking comments. We have written a point-by-point response for each of the reviewer 
suggestions. 
 
Comment 1. Thank you for your constructive comments. Within the public engagement 
framework, the pillars of ‘transmit’, ‘receive’ and ‘collaborate’ apply to the meningitis clinical 
research team. The specific pillar will vary according to the activity in question. For example, at 
the community advisory board (CAB) meeting the research team are receiving information and 
opinions from the CAB group and collaborating with the group in order to agree the best 
program of public outreach activities, taking into account their local expertise and knowledge. 
However, in the circus event, the research team are predominantly transmitting information to 
attendees/members of the public. We have now clarified this within the text describing each 
event.  
 
Comment 2. We have now completed the citation #6.  
  
Comment 3. Thank you for highlighting the important history of public engagement amongst 
PLHIV and the trail-blazing work of TASO. We have now adjusted our phrasing and specifically 
acknowledged his in our introduction and discussion, instead focussing on how important public 
engagement remains in research and how our work builds on the work of our predecessors and 
colleagues.  
 
Comment 4: Thanks for pointing this out, we have now explained the term lumbar punture in 
parentheses the first time this is mentioned in the text.  
 
Comment 5. The infographic leaflets were used along more detailed patient information leaflets, 
both of which were approved by the local research ethics committee. 
 
Comment 6. A short description has now been included in the figure legend.  
 
Comment 7. The journey of hope was a one-off event at the close of a phase II clinical trial. A 
phase III trial is just beginning and we hope to continue these events during and at the 
conclusion of ongoing/further studies.   
Additional citations, especially where statistics are provided, would strengthen this Letter, 
and benefit readers. For example, the following sentences ought to include references:  
  
Comment 8. Thanks for pointing out the missing citations – these have been added. 
 
Thank you for taking the time to read, critique and improve this work.   
Competing Interests: No competing interests were disclosed.
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© 2020 Kaida A. This is an open access peer review report distributed under the terms of the Creative Commons 
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the 
original work is properly cited.
Angela Kaida   
Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada 
Thank you for this opportunity to read and review this wonderful Open Letter. The authors 
describe their process of leading a series of community engagement activities to share clinical 
research findings with healthcare workers, participants, patients, and the general public. These 
efforts aimed to give clinical research participants a voice in sharing their experiences of 
participating in research, further messages of hope around advanced HIV disease, dispel HIV-
related myths and stigma, and disseminate recent research findings. I thank the investigators and 
co-authors for sharing their experiences and insights. 
 
I request that the authors replace the use of "HIV-positive" terminology with "people living with 
HIV", consistent with community-based research "people first" language. 
 
It would be helpful to include additional details about the evaluations undertaken, including 
whether the evaluation with the healthcare workers was formal (e.g., written anonymous 
evaluation forms) or informal (e.g., based on discussions held as part of the information session 
itself) and whether any recommendations were offered for ways to improve public engagement 
activities.
 
Is the rationale for the Open Letter provided in sufficient detail?
Yes
Does the article adequately reference differing views and opinions?
Yes
Are all factual statements correct, and are statements and arguments made adequately 
supported by citations?
Yes
Is the Open Letter written in accessible language?
Yes
Where applicable, are recommendations and next steps explained clearly for others to 
follow?
Yes
Competing Interests: No competing interests were disclosed.
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I confirm that I have read this submission and believe that I have an appropriate level of 
expertise to confirm that it is of an acceptable scientific standard.
Author Response 18 Oct 2020
fiona cresswell, Infectious Diseases Institute, Kampala, Uganda 
Many thanks for your positive feedback on our work and manuscript, gratefully received. We have 
corrected the language to PLHIV as suggested. Thank you for raising the important point of 
activity evaluations. The only event which we collected ‘formal’ feedback was for the circus event 
where exit interviews were conducted. At the healthcare worker ‘knowledge exchange’ events, we 
only received informal verbal feedback and it was not possible to evaluate the impact of the radio 
or TB event. In future events we like to create a formal feedback questionnaire so that 
improvements and suggestions can be documented and acted upon.   
Competing Interests: No competing interests were disclosed.
AAS Open Research
 
Page 14 of 14
AAS Open Research 2020, 3:33 Last updated: 13 JAN 2021
